These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 678161)

  • 1. [Hemodynamic effects of verapamil in patients with coronary insufficiency].
    Lamounier EN; Martinez EE; Herrmann JL; Guimarães RF; Martinez TL; Portugal OP
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():11-14. PubMed ID: 678161
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic evaluation of the action of calcium antagonists].
    Vincenzi M; Allegri P; Barbieri E; Cappelletti F; Carrozza A; De Lio U; Maiolino P; Morlino T; Ometto R
    Boll Soc Ital Cardiol; 1978; (1 Suppl):79-97. PubMed ID: 757682
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of verapamil in coronary insufficiency and cardiac arrhythmia].
    Bobkova VI; Solomonova LN; Majorov JM; Karpickij VS; Mazurova SV
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1285+. PubMed ID: 4098327
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic effects of verapamil and practolol in man.
    Seabra-Gomes R; Rickards A; Sutton R
    Eur J Cardiol; 1976 Mar; 4(1):79-85. PubMed ID: 1261583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Data on the effects of butydrine in patients with coronary insufficiency].
    De Maestri C; Rinaldi AR
    Minerva Cardioangiol; 1969 Feb; 17(2):142-50. PubMed ID: 5777638
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic and electrocardiographic effects of verapamil in ischemic cardiopathy].
    Aquaro G; Belli R; Ravera A; Rey L; Possavino G; Trucco G; Pavia M; Idone P
    Boll Soc Ital Cardiol; 1981; 26(12):2143-6. PubMed ID: 7185381
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamic effects caused by i.v. administration of verapamil in healthy subjects.
    Vincenzi M; Allegri P; Gabaldo S; Maiolino P; Ometto R
    Arzneimittelforschung; 1976; 26(6):1221-3. PubMed ID: 989421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of verapamil on coronary hemodynamics in patients with coronary heart disease.
    Simonsen S
    Eur J Cardiol; 1978 Aug; 8(1):9-18. PubMed ID: 689073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in infarct size following experimental coronary occlusion by administration of verapamil.
    Singh BN; Smith HJ; Norris RM
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():435-52. PubMed ID: 813284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic and coronary effects of intravenous verapamil in coronary insufficiency].
    Zygelman M; Mérillon JP; Guiomard A; Eustigneff T; Zannier D; Gourgon R
    Arch Mal Coeur Vaiss; 1981 Jun; 74(6):685-94. PubMed ID: 6794490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic and coronary changes induced by various slow-channel inhibitors in chronic coronary insufficiency: nifedipine, verapamil and bepridil].
    Merillon JP; Duffloux MA; Eustigneff T; Pansard Y; Guiomard A; Zygelman M; Aumont MC; Gourgon R
    Therapie; 1981; 36(2):123-34. PubMed ID: 6270840
    [No Abstract]   [Full Text] [Related]  

  • 12. [Isoptin studies on normal subjects and patients with coronary disease].
    Knoch G; Schlepper M; Witzleb E
    Med Klin; 1963 Sep; 58(36):1485-9. PubMed ID: 5889185
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and hemodynamic evaluation of the use of verapamil in stenocardia].
    Roma F; Taurino L; Miccoli A
    Boll Soc Ital Cardiol; 1975; 20(4):343-50. PubMed ID: 1231914
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of action of verapamil in ischemic heart disease: observations on changes in systemic and coronary hemodynamics and coronary vasomobility.
    Chew CY; Brown BG; Singh BN; Hecht HS; Schnugg SJ; Wong M; Shah PM; Dodge HT
    Clin Invest Med; 1980; 3(1-2):151-8. PubMed ID: 7008996
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of propranolol on circulatory hemodynamics of patients with coronary heart failure in the light of polycardiographic examination.
    Mazurowa A; Tracz W
    Pol Med J; 1970; 9(4):827-34. PubMed ID: 5477489
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of the acute hemodynamic effects of verapamil and nifedipine in patients with ischemic heart disease].
    Manfroi WC; Vieira SR; Ludwig RT; Goldim JR; Faraco EZ
    Arq Bras Cardiol; 1987 Feb; 48(2):123-8. PubMed ID: 3675228
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiovascular effects of the slow intravenous infusion of verapamil].
    de Moura RS
    Arq Bras Cardiol; 1982 Feb; 38(2):111-4. PubMed ID: 7159243
    [No Abstract]   [Full Text] [Related]  

  • 18. [Unstable stenocardia: hemodynamic effect of the intravenous administration of verapamil].
    Karpov IuA; Gratsianskiĭ NA; Ruda MIa
    Ter Arkh; 1986; 58(5):81-4. PubMed ID: 3738799
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of verapamil on major events in patients with exercise-induced ischemia recovering from acute myocardial infarction: a review. The Danish Study Group on Verapamil in Myocardial Infarction.
    Jespersen CM
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S30-2. PubMed ID: 1725914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic dose-response effects of i.v. verapamil in coronary artery disease.
    Silke B; Verma SP; Ahuja RC; Nelson GI; Hussain M; Taylor SH
    Herz; 1984 Dec; 9(6):353-61. PubMed ID: 6510876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.